Phase 3 Autism Spectrum Disorder Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Children aged between 3 years and 12 years and 11 months old
• Children who have been formally diagnosed with autism spectrum disorder using specific standardised diagnostic tools
• Children whose repetitive or rigid behaviours are at least moderately severe, as measured by a specific scoring tool used in autism research
• Children who have not yet started puberty, based on standard physical development guidelines
• Children whose family lives within 300 miles of the main study location may need to pass a safety screening for MRI scanning and attempt a brain scan at the start of the study; children living further away do not need to do this
• Children who have been on a stable medication routine for at least 30 days and a stable behavioural or therapy program for at least 60 days before joining, with no planned changes during the trial

Who may not be able to join:

• Children who have a known genetic condition linked to autism, such as Fragile X syndrome
• Children who have ever been diagnosed with a serious psychiatric condition, such as schizophrenia
• Children who have significant ongoing medical problems
• Children whose primary caregiver is not able to speak and read English well enough to participate
• Children who are currently taking glutathione supplements or related compounds
• Children who have previously had a bad reaction to glutathione supplements or related compounds
• Children who are unable to drink a sample of the study substance mixed into a liquid

Important: Always verify eligibility with the trial site directly before applying.